Clinical Trial Update: Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SYNC-T immunotherapy in patients with advanced or metastatic solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Solid Tumor

Drugs mentioned

• SYNC-T

Snippet

Sponsor: Williams Cancer Foundation | Conditions: Metastatic Cancer, Metastatic Breast Cancer | Phase 1 | Status: RECRUITING